Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Capping actin protein of muscle Z-line subunit alpha-3 (CAPZA3) is an F-actin-capping protein alpha subunit predominantly expressed in germ cells, particularly sperm. It binds to the barbed (fast-growing) ends of actin filaments in a calcium-independent manner, blocking the addition or removal of actin monomers at these ends and thus stabilizing filament length. CAPZA3 is mainly localized to the neck region of sperm and also found in the tail and postacrosomal regions, suggesting a role in sperm architecture and fertility. Unlike some related proteins (such as gelsolin), CAPZA3 does not sever actin filaments. Disruption of this gene has been associated with impaired sperm structure and male infertility, particularly globozoospermia[2][3][4]. There is currently no evidence that CAPZA3 is directly targeted by therapeutic drugs or is itself a druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capping actin protein of muscle Z-line subunit alpha-3 (CAPZA3).